A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria
Bull. W.H.O. (Print)
; 65(3): 357-361, 1987.
Article
in English
| WHO IRIS
| ID: who-264448
Responsible library:
CH1.1
Full text:
Available
Collection:
Databases of international organizations
Health context:
Neglected Diseases
Health problem:
Malaria
/
Neglected Diseases
Database:
WHO IRIS
Main subject:
Research
Language:
English
Journal:
Bull. W.H.O. (Print)
Year:
1987
Document type:
Article